COVID-19 as an acute inflammatory disease
RH Manjili, M Zarei, M Habibi… - The journal of immunology, 2020 - journals.aai.org
Abstract The 2019 coronavirus disease (COVID-19) pandemic caused by the virus severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has created an unprecedented …
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has created an unprecedented …
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
Background Whereas severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-
specific antibody tests are increasingly being used to estimate the prevalence of SARS-CoV …
specific antibody tests are increasingly being used to estimate the prevalence of SARS-CoV …
A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2
Abstract In December 2019, China reported the first cases of the coronavirus disease 2019
(COVID‐19). This disease, caused by the severe acute respiratory syndrome–related …
(COVID‐19). This disease, caused by the severe acute respiratory syndrome–related …
Different innate and adaptive immune responses to SARS-CoV-2 infection of asymptomatic, mild, and severe cases
R Carsetti, S Zaffina, E Piano Mortari, S Terreri… - Frontiers in …, 2020 - frontiersin.org
SARS-CoV-2 is a novel coronavirus, not encountered before by humans. The wide spectrum
of clinical expression of SARS-CoV-2 illness suggests that individual immune responses to …
of clinical expression of SARS-CoV-2 illness suggests that individual immune responses to …
Severe COVID-19 and sepsis: immune pathogenesis and laboratory markers
The ongoing outbreak of the novel coronavirus disease 2019 (COVID-19), induced by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has taken a significant toll …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has taken a significant toll …
COVID-19: immunopathogenesis and Immunotherapeutics
L Yang, S Liu, J Liu, Z Zhang, X Wan… - Signal transduction and …, 2020 - nature.com
The recent novel coronavirus disease (COVID-19) outbreak, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected …
respiratory syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected …
Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects
J Zheng, Y Deng, Z Zhao, B Mao, M Lu, Y Lin… - Cellular & molecular …, 2022 - nature.com
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is an ongoing pandemic that poses a great threat to …
syndrome coronavirus 2 (SARS-CoV-2), is an ongoing pandemic that poses a great threat to …
Dysregulation of the immune response in coronavirus disease 2019
L Mohamed Khosroshahi, N Rezaei - Cell Biology International, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) can trigger a cytokine
storm in the pulmonary tissue by releasing various types of mediators, leading to acute …
storm in the pulmonary tissue by releasing various types of mediators, leading to acute …
Impaired cellular immunity to SARS-CoV-2 in severe COVID-19 patients
L Ni, ML Cheng, Y Feng, H Zhao, J Liu, F Ye… - Frontiers in …, 2021 - frontiersin.org
The high infection rate and rapid spread of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) make it a world-wide pandemic. Individuals infected by the virus exhibited …
(SARS-CoV-2) make it a world-wide pandemic. Individuals infected by the virus exhibited …
COVID-19: an immunopathological view
K Kadkhoda - MSphere, 2020 - Am Soc Microbiol
Since its emergence in December 2019, it took only a couple of months for an outbreak of
the novel coronavirus disease 2019 (COVID-19) to be declared a pandemic by the World …
the novel coronavirus disease 2019 (COVID-19) to be declared a pandemic by the World …